Intrinsic Value of S&P & Nasdaq Contact Us

First Wave BioPharma, Inc. FWBI NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
44/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — FWBI

First Wave BioPharma, Inc. (FWBI) has a market capitalization of $5.99M and trades at $2.96. The 52-week range is 2.3335-59.998.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $-5.33.

The stock has a beta of 1.28, operates in the Healthcare sector.

Trading Data
Current Price$2.96
52-Week Range2.3335-59.998
Volume56.36K
Avg Volume (30D)72.48K
Market Cap$5.99M
Beta (1Y)1.28
Company
IPO Date2016-10-11
Employees9
CEOJames R. Sapirstein
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS33749P4081
CUSIP33749P101
Income (Latest Year)
EBITDA$-15.62M
Operating Income$-15.62M
Net Income$-18.06M
EPS$-5.33
EPS Diluted$-5.33
Shares Outstanding$3.43M
Balance Sheet (Latest Year)
Total Assets$85.41M
Current Assets$83.48M
Cash & ST Investments$163.48K
Total Liabilities$27.61M
Total Debt$140.53K
Net Debt$-22.94K
Valuation Ratios
P/E Ratio-0.6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message